OnDemand WTP Pricing Research

BioTelemetry: Key Partnership In Apple’s Heart Study Featuring Apple’s Watch – BioTelemetry, Inc. (NASDAQ:BEAT) | Seeking Alpha

According to Apple’s last earnings call, the company’s Watch has had unit growth of 50% for the third consecutive quarter, establishing itself as arguably the best selling smartwatch in the world. Apple describes its watch during the call as “the ultimate device for a healthy life” and is doubling down on its statement by collaborating not only with leading health physicians, but also a cutting edge cardiac monitoring company like BioTelemetry for its upcoming health study. For Apple to maintain its premium pricing strategy across its ecosystem, only the best will do. Apple has had great success at building its ecosystem of products that are indispensable and “sticky” for its customers as it provides not only hardware, but also great software and services. Apple Watch’s growth has been tremendous over the past few quarters, and progressing in the future to advanced real-time accurate cardiac monitoring along with other features will only serve to make the device even more indispensable to users.

Read complete article here:

BioTelemetry: Key Partnership In Apple’s Heart Study Featuring Apple’s Watch – BioTelemetry, Inc. (NASDAQ:BEAT) | Seeking Alpha.

Post a Comment

WP-SpamFree by Pole Position Marketing